1.The effective components of Chinese medicine combined with scaffold materials promote bone tissue regeneration
Xinyu DONG ; Xinyue DONG ; Wanting WANG ; Haixia FAN ; Huanzhi CHENG
Chinese Journal of Tissue Engineering Research 2024;28(20):3240-3245
BACKGROUND:With the proven ability of traditional Chinese medicine such as icariin and berberine to promote bone regeneration by regulating various mechanisms and targets,researchers have combined active ingredients of traditional Chinese medicine with bone tissue engineering and found that they have unique advantages in treating bone defects. OBJECTIVE:Starting from the active ingredients of traditional Chinese medicines that promote bone formation,to screen cases of their effective combination with different drug-carrying scaffold materials,and summarize the active ingredients of traditional Chinese medicines that have the potential to be applied to bone tissue engineering. METHODS:CNKI,WanFang,PubMed,and Web of Science were searched for relevant literature published from 2000 to 2023,using the keywords of"bone tissue engineering,bone tissue-engineered scaffold materials,bone defect,bone repair,bone regeneration,traditional Chinese medicine"in Chinese and English.According to the inclusion and exclusion criteria,87 papers were finally included for review. RESULTS AND CONCLUSION:There are various kinds of active ingredients of traditional Chinese medicine to promote bone regeneration,mainly including flavonoids,non-flavonoid polyphenols,alkaloids,glycosides.These active ingredients have anti-inflammatory and analgesic effects,promote osteoblasts,inhibit osteoclasts and promote early angiogenesis.The combination of active ingredients of traditional Chinese medicine with bone tissue engineering is effective in anti-inflammation,accelerating collagen and bone formation,and promoting the expression of osteogenic genes,which provides a theoretical basis for the application of traditional Chinese medicine in bone tissue regeneration,and at the same time provides a new idea for the repair of bone defects.
2.The pathogenesis of dry eye disease was explored based on the Wnt/β-catenin pathway
Hui Dong ; Jia Liu ; Tianqi Zhao ; Haixia Zhao
Acta Universitatis Medicinalis Anhui 2024;59(12):2246-2251
Abstract
Dry eye disease is a chronic ocular surface inflammatory disease caused by abnormal tear quality or quantity and decreased tear film stability due to various reasons, and often accompanied by ocular discomfort such as itching, dryness, foreign body sensation, and visual dysfunction, which can seriously affect the patient′s quality of life and visual quality if not intervened in time. With the change of social lifestyles, the increase of environmental pollution and the trend of population aging, dry eye disease has become the most common ocular surface disease besides refractive error. Currently, dry eye disease is widely recognized as a non-infectious immune-related inflammatory disease, but the signaling pathways involved in dry eye disease are poorly understood. Whether dry eye disease is caused by excessive tear evaporation, insufficient tear production, or mucin deficiency, the ocular surface tissues(cornea/conjunctiva) inevitably undergo pathological processes such as aberrant proliferation, squamous epithelial hyperplasia, initiation of corneal damage repair mechanisms, and reduction in the number of conjunctival goblet cells, whereas the Wnt/β-catenin pathway is known to have a wide range of biological functions and plays an important role in cell proliferation, differentiation, and stemness maintenance. Therefore, this review describes the pathogenesis and potential experimental therapeutic options of the Wnt/β-catenin signaling pathway in dry eye disease from this perspective, aiming to provide new targets for the treatment of dry eye disease and achieve the goal of controlling the disease progression from the root.
3.A comparative analysis of four methods for eliminating M protein interference in serum uric acid detection
Dong XU ; Tao MENG ; Jian CHEN ; Haixia LI
Chinese Journal of Clinical Laboratory Science 2024;42(10):728-732
Objective To compare the differences among dilution method,polyethylene glycol(PEG)precipitation method,ultrafil-tration membrane filtration method,and manual calculation method in eliminating M protein interference in uric acid detection and eval-uate their clinical application value.Methods The serum samples affected by M protein interference were subjected to uric acid detec-tion and calculation using dilution method(deionized water and physiological saline),PEG precipitation method,ultrafiltration mem-brane filtration method,and manual calculation method.The values of obtained from the four methods were compared,and the result of ultrafiltration membrane filtration method was used as the reference value.Results The relative biases between the results of the dilu-tion method and the ultrafiltration method after different dilutions of deionized water and physiological saline were as follows:-32.38%and-60.66%at 3-fold dilution,-26.23%and-46.72%at 5-fold dilution,and-22.13%and-30.33%at 10-fold dilution.The rela-tive bias between the PEG precipitation method and the ultrafiltration method was-3.28%.The bias before and after PEG precipitation in 10 control samples ranged from-3.80%to 2.34%.The relative bias between the results of the ultrafiltration membrane filtration method and the patient's original results was 687.10%.The biases of the manual calculation method compared to PEG precipitation method and the ultrafiltration membrane filtration method were-1.64%and 1.69%,respectively.The biases of 10 control samples were between-4.62%and 0%.Conclusion The four methods for clearing M protein interference in uric acid detection have their own ad-vantages and disadvantages in terms of accuracy,convenience,cost-effectiveness,and practicality.PEG precipitation method and ultra-filtration membrane filtration method have the highest accuracy,but they were more cumbersome to operate and have higher consumable costs.The dilution method was easy to perform and has good practicality and cost-effectiveness,but its accuracy was poor.The manual calculation method requires good understanding of uric acid detection parameters and instrument detection principles.Its calculation re-sults were close to those of the ultrafiltration membrane filtration method,making it convenient,economical,and rapid,and it could be used as routine clinical method.
4.Frequency survey of blood group PP1PK in Chinese Lahu Population
Haixia HU ; Liangfeng FAN ; Chengjiang FANG ; Dong XIANG ; Dan WU
Chinese Journal of Blood Transfusion 2023;36(9):847-850
【Objective】 To investigate the frequency of P1PK and GLOB blood group in Chinese Lahu population and their genetic status, so as to provide data support for the safety of blood transfusion and give advice and transfusion guidance for pregnant women. 【Methods】 Unrelated individuals of Chinese Lahu population were randomly selected for serological identification of P1PK and P blood group and gene sequencing analysis. The frequency of P1PK and GLOB blood group were analyzed. 【Results】 Six cases of anti-PP 1Pk(formerly known as anti-Tja) negative blood type were identified as the rare P1-PK-P- blood type (formerly known as Tja- blood type or p blood type, hereinafter referred to as p blood group) from 300 Lahu population, with phenotypic frequency of p blood group in P1PK and GLOB blood group system in Lahu population at 2.0%(6/300). 【Conclusion】 The phenotypic frequency of blood group p in Lahu population was significantly higher than that in Europe (5.8 persons per million) and Hong Kong, China (1 person per million),indicating significant ethnic specificity and regional ethnic differences.
5.Analysis of ADNP gene variant in a child with Helsmoortel-van der Aa syndrome.
Jian MA ; Haixia MA ; Kaihui ZHANG ; Yuqiang LYU ; Min GAO ; Dong WANG ; Zhongtao GAI ; Yi LIU
Chinese Journal of Medical Genetics 2022;39(4):428-432
OBJECTIVE:
To explore the genetic basis for a child manifesting with intellectual disability, language delay and autism spectrum disorder.
METHODS:
Genomic DNA was extracted from peripheral blood samples of the child and his family members, and subjected to whole exome sequencing. Candidate variants were verified by Sanger sequencing and interpreted according to the guidelines of the American College of Medical Genetics and Genomics.
RESULTS:
The child was found to harbor a heterozygous c.568C>T (p.Q190X) nonsense variant of the ADNP gene, which was not detected in either parent by Sanger sequencing.
CONCLUSION
The clinical and genetic testing both suggested that the child has Helsmoortel-van der Aa syndrome due to ADNP gene mutation, which is extremely rare in China.
Abnormalities, Multiple/genetics*
;
Autism Spectrum Disorder/genetics*
;
Autistic Disorder/genetics*
;
Child
;
Heterozygote
;
Homeodomain Proteins/genetics*
;
Humans
;
Intellectual Disability/genetics*
;
Mutation
;
Nerve Tissue Proteins/genetics*
;
Rare Diseases
6.Distribution of ABO, Rh, Mn, P, h blood groups and gene frequency in Lahu ethnic minority in Yunnan
Haixia HU ; Chengjiang FANG ; Dan WU ; Yu WU ; Chen WANG ; Zhongying WANG ; Yuyu ZHANG ; Dong XIANG ; Zhenrong ZHANG
Chinese Journal of Blood Transfusion 2022;35(10):1059-1061
【Objective】 To understand the distribution and gene frequency of main red blood cell blood groups in Lahu ethnic minority and analyze the genetic characteristics of Lahu people. 【Methods】 1) ABO forward and reverse typing had been performed by microplate method; 2) Rh, MN, H, P1Pk and Mur antigen were tested by the tube method. If the ABO forward and reverse typing were incompatible, the tube method was used for confirmation. 【Results】 The distribution characteristics of blood group and gene frequency in Lahu ethnic minority were as follows: B>O>A>AB for ABO, with genotype frequency as p 11.1%, q 27.5% and r 61.4%; the frequency of Rh genotype was CDe 83.3%, cDE 12.0%, cDe 2.42%, CDE 2.32%, CdE 0%, Cde 0%, cdE 0% and cde 0%; M > MN>N for MN blood group, with genotype frequency as M 75.26% and N 24.74%; P1
7.Value of nasobiliary cholangiography in the diagnosis of residual common bile duct stones after endoscopic retrograde cholangiopancreatography and related factors of residual common bile duct stones
Dapeng BIAN ; Jinpei DONG ; Haixia NIU ; Yinmo YANG ; Qiushi FENG
Journal of Clinical Hepatology 2021;37(4):868-871
ObjectiveTo investigate the value of nasobiliary cholangiography in the diagnosis of residual common bile duct stones after endoscopic retrograde cholangiopancreatography (ERCP) and the risk factors for residual stones. MethodsA retrospective analysis was performed for the clinical data of the patients who underwent ERCP and nasobiliary cholangiography after endoscopic nasobiliary drainage in Peking University First Hospital from January 1, 2018 to December 31, 2019. The chi-square test was used for comparison of categorical data between groups, and a logistic regression analysis was used to investigate independent risk factors for residual stones. ResultsA total of 366 patients underwent ERCP and nasobiliary cholangiography and 27 patients were suspected to have residual stones, among whom 25 had residual stones confirmed by ERCP. The rate of residual stones after ERCP was 6.8% (25/366), and nasobiliary cholangiography had a positive predictive value of 92.6% (25/27) in predicting residual common bile duct stones. The univariate analysis showed that there were significant differences between the two groups in multiple stones, common bile duct diameter ≥1.5 cm, and mechanical lithotripsy (χ2=5014, 7.651, and 9.670, all P<0.05). The multivariate logistic regression analysis showed that multiple stones (odds ratio [OR]=2713, 95% confidence interval [CI]: 1.002-7.345, P=0.049) and mechanical lithotripsy (OR=9.183, 95% CI: 2.347-35.925, P=0.001) were independent risk factors for residual stones. ConclusionPost-ERCP nasobiliary cholangiography is an effective method to detect residual common bile duct stones. Multiple stones and mechanical lithotripsy during ERCP are independent risk factors for residual stones.
8.Application of the best evidence for screening and evaluating cancer-related fatigue in patients with lung cancer undergoing chemotherapy
Haiyan ZHAO ; Weijuan CHEN ; Dong KONG ; Xin CUI ; Sai JI ; Haixia WANG ; Lijuan YANG
Chinese Journal of Modern Nursing 2021;27(12):1571-1578
Objective:To summarize the best evidences for screening and evaluation of cancer-related fatigue in patients with lung cancer undergoing chemotherapy and apply them to clinical nursing practice, so as to improve clinical nursing service, reduce the level of cancer-related fatigue and improve the quality of life of patients.Methods:Using the convenient sampling method, a total of 48 patients with lung cancer undergoing chemotherapy who were admitted to Department of Respiratory and Critical Care Medicine in Shandong Provincial Hospital Affiliated to Shandong First Medical University from May 6 to June 28, 2019 were selected as the control group, while 50 patients who were admitted from September 2 to October 30, 2019 were selected as the observation group. Joanna Briggs Institute (JBI) Practical Application of Clinical Evidence System (PACES) was used as a review tool to screen the detection rate of cancer-related fatigue of patients after the application of evidence and investigate the implementation rate of nurses' review standards. The scores of Nurses' Knowledge, Attitude and Practice Questionnaire on Cancer-related Fatigue Management and the Chinese version of European Organization for Research and Treatment Quality of Life Questionnaire-Core 30 V3.0, EORTC-C30 V3.0 (EORTC-C30 V3.0) were compared before and after the use of evidence. The t test was used to compare the measurement data between the two groups, and the χ 2 test or Fisher's exact test was used to compare the enumeration data. Results:The implementation rates of review indicators after the application of evidence reached 86% (43/50) to 100% (50/50) . After application of the evidence, scores of knowledge, attitude and practice dimensions of Nurses' Knowledge, Attitude and Practice Questionnaire on Cancer-related Fatigue Management were respectively (99.50±1.37) , (39.06±1.00) and (30.69±1.08) , which were all higher than those before the evidence was applied, and the differences were statistically significant ( t=-16.023, -7.258, -19.769; P<0.05) . The detection rates of mild, moderate and severe fatigue in the observation group were 52% (26/50) , 26% (13/50) and 6% (3/50) , respectively. The scores of body, role, cognitive, emotional function and general health status in the Chinese version of EORTC-C30 V3.0 in the observation group were higher than those in the control group, while the score of fatigue dimension was lower than that in the control group, and the differences were statistically significant ( t=-3.193, -2.487, -3.743, -2.202, -1.067, -3.100, 3.273; P<0.05) . Conclusions:The best evidence for screening and evaluation of cancer-related fatigue in patients undergoing chemotherapy for lung cancer can provide evidence-based evidence for clinical fatigue management, and its clinical application can improve the identification and management of cancer-related fatigue, standardize nurse behavior, and improve the quality of life of patients.
9.The phenotypes and genotypes in 314 patients with isolated methylmalonic acidemia
Lulu KANG ; Yupeng LIU ; Ming SHEN ; Zhehui CHEN ; Jinqing SONG ; Ruxuan HE ; Yi LIU ; Yao ZHANG ; Hui DONG ; Mengqiu LI ; Ying JIN ; Hong ZHENG ; Qiao WANG ; Yuan DING ; Xiyuan LI ; Dongxiao LI ; Haixia LI ; Xueqin LIU ; Huijie XIAO ; Yuwu JIANG ; Hui XIONG ; Chunyan ZHANG ; Zhaoxia WANG ; Yun YUAN ; Desheng LIANG ; Yaping TIAN ; Yanling YANG
Chinese Journal of Pediatrics 2020;58(6):468-475
Objectives:To summarize the clinical and genetic characteristics of the patients with isolated methylmalonic acidemia and investigate the strategies for the diagnosis, treatment and prevention.Methods:Three hundred and fourteen patients (180 males, 134 females) with isolated methylmalonic acidemia were ascertained from 26 provinces or cities across the mainland of China during January 1998 to March 2020. Genetic analysis was performed by Sanger sequencing, gene panel sequencing, whole exome sequencing, multiplex ligation-dependent probe amplification or quantitative PCR. According to the age of onset, the patients were divided to early-onset group (≤12 months of age) and the late-onset group (>12 months of age). They were treated by cobalamin, L-carnitine and (or) special diet and symptomatic treatment. Statistical analysis was done using Chi-square test.Results:Fifty-eight of 314 (18.5%) patients were detected by Newborn screening using liquid chromatography tandem mass spectrometry. Five cases (1.6%) had a postmortem diagnosis. Two hundred and fifty-one patients (79.9%) were clinically diagnosed with an age of onset ranged from 3 hours after birth to 18 years. One hundred and fifty-nine patients (71.0%) belonged to early-onset groups, 65 patients (29.0%) belonged to the late-onset group. The most common symptoms were metabolic crises, psychomotor retardation, epilepsy, anemia and multiple organ damage. Metabolic acidosis and anemia were more common in early-onset patients than that in late-onset patients (20.8%(33/159) vs. 9.2% (6/65), 34.6% (55/159) vs. 16.9% (11/165), χ 2=4.261, 6.930, P=0.039, 0.008). Genetic tests were performed for 236 patients (75.2%), 96.2%(227/236) had molecular confirmation. One hundred and twenty-seven variants were identified in seven genes (MMUT, MMAA, MMAB, MMADHC, SUCLG1, SUCLA2, and MCEE), of which 49 were novel. The mut type, caused by the deficiency of methylmalonyl-CoA mutase, was the most common ( n=211, 93%) cause of this condition. c.729_730insTT, c.1106G>A and c.914T>C were the three most frequent mutations in MMUT gene. The frequency of c.914T>C in early-onset patients was significantly higher than that in late-onset patients (8.3% (18/216) vs. 1.6% (1/64), χ 2=3.859, P=0.037). Metabolic crisis was more frequent in mut type than the other types (72.6% (114/157) vs. 3/13, χ 2=13.729, P=0.001),developmental delay and hypotonia were less frequent in mut type (38.2% (60/157) vs. 9/13, 25.5% (40/157) vs. 8/13, χ 2=4.789, 7.705, P=0.030, 0.006). Of the 58 patients identified by newborn screening, 44 patients (75.9%) who were treated from asymptomatic phase developed normally whereas 14 patients (24.1%) who received treatment after developing symptoms exhibited varying degrees of psychomotor retardation. Conclusions:The characteristics of phenotypes and genotypes among Chinese patients with isolated methylmalonic acidemia were analyzed. Expanded the mutation spectrum of the associated genes. Because of the complex clinical manifestations and severe early onset of isolated methylmalonic acidemia, Newborn screening is crucial for early diagnosis and improvement of prognosis. MMUT gene is recommended for carrier screening as an effort to move the test earlier as a part of the primary prevention of birth defects.
10.Observation on therapeutic effects Yanshu compound radix sophore injection for treatment of patients with bone metastasis pain of lung cancer
Shihong WEI ; Yuexiao QI ; Yumei DONG ; Liyun GUO ; Haixia SONG ; Hongtao LUO ; Ruifeng LIU ; Yan XiaojunLin XIA
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2019;26(3):357-360
Objective To observe the clinical effect of Yanshu compound radix sophore injection combined with radiotherapy in treatment of patients with bone metastases from lung cancer. Methods A total of 116 patients with bone metastases from lung cancer admitted to the Department of Radiation Oncology of Gansu Provincial Cancer Hospital from January 2014 to December 2018 were selected. The 58 patients were treated by using three-dimensional conformal radiotherapy (3D-CRT), zoledronic acid and oxycodone sustained-release tablets (control group); the others 58 patients were treated radix sphore injection on basis of control group (integrated Chinese and western medicine). The two groups were treated continuously for 10 days as 1 course of treatment, taking a rest for one week in the middle, then they took the second course of treatment; after the end of 2 courses, the therapeutic effects were evaluated in the two groups. The pain grading, Karnofsky functional status (KPS) score and myelosuppression were observed before and after treatment in two groups, respectively. Results The proportions of patients with painless and mild pain after treatment in the integrated Chinese and western medicine group were significantly lower than those in control group [painless: 22.41% (13/58) vs. 39.66% (23/58), mild pain: 10.35% (6/58) vs. 46.55% (27/58)], while the proportions of patients with moderate pain and severe pain in the integrated Chinese and western medicine group were significantly higher than those of the control group [moderate pain: 53.45(31/58) vs. 12.07% (7/58), severe pain: 13.79% (8/58) vs 1.72% (1/58), both P < 0.05]. After treatment, the proportion of patients with improved KPS score in integrated Chinese and western medicine group was significantly higher than that in control group [55.17% (32/58) vs. 36.21% (21/58), P < 0.05], and the proportion of patients with stable and decreased KPS score were less than that of control group [stable KPS score:18.97%(11/58) vs. 27.59%(16/58), decreased KPS score:25.86% (15/58) vs. 36.21% (21/58)]. The proportions of patients with blood cell count (WBC), hemoglobin (Hb) and platelet count (PLT) showing no myelosuppression (at the zero degree) after treatment in integrated Chinese and western medicine group were obviously higher than those in control group [WBC: 77.59% (45/58) vs. 36.21% (21/58), Hb: 77.59% (45/58) vs. 70.69% (41/58), PLT: 58.62% (34/58) vs. 32.76% (19/58), all P < 0.05]. Conclusion Yanshu compound radix sphore injection combined with radiotherapy can reudce bone metastasis pain, reduce bone marrow suppression and improve quality of life in patients with advanced lung cancer and bone metastasis.


Result Analysis
Print
Save
E-mail